Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Elixir Department: SOP for Control and Use of Primary Containers During Dispensing – V 2.0

Posted on By

Elixir Department: SOP for Control and Use of Primary Containers During Dispensing – V 2.0

Standard Operating Procedure for Control and Use of Primary Containers During Dispensing

Department Elixir Department
SOP No. SOP/ELX/025/2025
Supersedes SOP/ELX/025/2022
Page No. Page 1 of 8
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define a standard procedure for the control, handling, labeling, and use of primary containers during the dispensing of raw materials in the Elixir Department, ensuring traceability and compliance with cGMP standards.

2. Scope

This SOP is applicable to all primary containers (original raw material containers, partially used containers, and repacked containers) used during the dispensing of raw materials for elixir manufacturing.

3. Responsibilities

  • Dispensing Operator:
    • Ensure containers are handled hygienically and labeled correctly.
    • Seal and return unused materials properly.
  • Warehouse Staff:
    • Maintain record of container movement and segregation.
  • QA Officer:
    • Verify integrity and labeling of all containers during dispensing and after return.
See also  Elixir Department: SOP for Verification of Raw Materials Before Dispensing - V 2.0

4. Accountability

The Head of QA and Head of Warehouse are accountable for ensuring appropriate use and control of primary containers during dispensing operations.

5. Procedure

5.1 Verification of Containers

  1. Check each container for:
    • Correct label (material name, code, batch number, expiry)
    • Physical condition – no leakage, dents, or tampering
    • Proper closure and tamper-evident seals
  2. Confirm the material against the Material Requisition Slip and Approved Vendor List.

5.2 Use During Dispensing

  1. Do not open more containers than required for the current batch.
  2. Open containers only under controlled and clean environment (preferably under LAF).
  3. Do not mix contents of two containers without QA approval.
  4. Use separate scoops and weighing aids for each material.

5.3 Labeling Requirements

  1. Ensure original manufacturer’s label remains intact and readable at all times.
  2. If material is repacked, affix secondary label with:
    • Material name and code
    • Repack date and expiry
    • Repacked by and verified by
  3. Label all partially used containers as “Partially Used” with remaining quantity, date, and signature (refer Annexure-1).
See also  Elixir Department: SOP for Environmental Monitoring of Dispensing Area - V 2.0

5.4 Handling of Unused Materials

  1. Seal all partially used containers immediately after dispensing.
  2. Wipe the exterior with lint-free cloth soaked in 70% IPA.
  3. Transfer to the quarantine area for further disposition (reuse, re-testing, or disposal).

5.5 Rejected Containers

  1. Segregate any container with damaged packaging, illegible labeling, or leakage.
  2. Label as “REJECTED – DO NOT USE.”
  3. Inform QA and record in the Rejection Log (Annexure-2).

5.6 Traceability and Documentation

  1. Record container IDs, batch numbers, and quantity dispensed in the Dispensing Log.
  2. Maintain traceability from receipt to issuance and return of containers.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • IPA: Isopropyl Alcohol
See also  Elixir Department: SOP for Handling Rejected Raw Materials During Dispensing - V 2.0

7. Documents

  1. Partially Used Container Label (Annexure-1)
  2. Container Rejection Log (Annexure-2)

8. References

  • WHO TRS 986 Annex 2 – GMP Guidelines
  • 21 CFR Part 211 – Subpart E: Control of Components

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Partially Used Container Label

Material Name Batch No. Remaining Qty Date Repacked/Used By Verified By
Citric Acid CA0425 3.0 kg 13/04/2025 Rajesh Kumar Sunita Reddy

Annexure-2: Container Rejection Log

Date Container ID Material Name Reason for Rejection Rejected By QA Verification
13/04/2025 CTN-0789 Glycerin Seal Broken Rajesh Kumar Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
10/01/2022 1.0 Initial SOP New SOP QA Head
13/04/2025 2.0 Added labeling and traceability protocols Audit Recommendation QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Analytical Method Development: Drafting Analytical Specifications – V 2.0
Next Post: API Manufacturing: SOP for Temperature Mapping in Drying Chambers – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version